Overview Super Micro Computer, Inc.

The Investor Relations website contains information about Super Micro Computer, Inc.s business for stockholders, potential investors, and financial analysts.

OVERVIEW

This site ir.supermicro.com presently has a traffic classification of zero (the lower the superior). We have sifted nineteen pages within the website ir.supermicro.com and found one hundred and seventy-four websites referencing ir.supermicro.com.
Pages Analyzed
19
Links to this site
174

IR.SUPERMICRO.COM RANKINGS

This site ir.supermicro.com is seeing fluctuating levels of traffic for the duration of the year.
Traffic for ir.supermicro.com

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for ir.supermicro.com

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for ir.supermicro.com

Date Range

All time
This Year
Last Year
Last Month

LINKS TO WEB PAGE

Rugged Industrial Military Computers, PC, Electronics Crystal Group

NEW RACE Rugged Autonomous Computer Equipment. Are on the line,. NEW FORCE Rugged Servers - Learn More.

Supermicro Reseller Resource Center Supermicro Reseller Resource Center

Welcome to Supermicro Reseller site. Other products and companies referred to herein are trademarks or registered trademarks of their respective companies or mark holders.

WHAT DOES IR.SUPERMICRO.COM LOOK LIKE?

Desktop Screenshot of ir.supermicro.com Mobile Screenshot of ir.supermicro.com Tablet Screenshot of ir.supermicro.com

IR.SUPERMICRO.COM HOST

We diagnosed that the main root page on ir.supermicro.com took two hundred and sixty-five milliseconds to come up. Our crawlers could not discover a SSL certificate, so our crawlers consider ir.supermicro.com not secure.
Load time
0.265 seconds
SSL
NOT SECURE
Internet Address
23.213.123.49

FAVORITE ICON

SERVER OPERATING SYSTEM

I discovered that this domain is implementing the nginx os.

PAGE TITLE

Overview Super Micro Computer, Inc.

DESCRIPTION

The Investor Relations website contains information about Super Micro Computer, Inc.s business for stockholders, potential investors, and financial analysts.

CONTENT

This site states the following, "Read more about our management team here." Our analyzers observed that the web page stated " Read more about our Board of Directors here." The Website also stated " Supermicros New Scale-Up Artificial Intelligence and Machine Learning Systems with 8 NVIDIA Tesla V100 with NVLink GPUs Deliver Superior Performance and System Density. Supermicro Unleashes Innovative New Resource Saving Datacenter Solutions at Cloud Expo Europe 2018. And are also available in pertinent news releases from the company."

VIEW MORE WEB SITES

Investor Relations - Supernus Pharmaceuticals, Inc.

Delayed at least 20 minutes. 2018 Supernus Pharmaceuticals, Inc.

SÜSS MicroTec - Investor Relations

Willkommen im Investor Relations Bereich der SÜSS MicroTec AG. Das Ziel der Investor Relations Arbeit bei SÜSS MicroTec ist es für eine angemessene Bewertung unserer Aktie am Kapitalmarkt zu sorgen. Aus diesem Grund pflegen wir einen intensiven Kontakt zu unseren Aktionären und stehen darüber hinaus im offenen und kontinuierlichen Dialog mit dem Kapitalmarkt.

Investor Relations Swire Properties

Notices - Replacement of Lost Share Certificates. List of Directors and their Role and Function. Memorandum and Articles of Association. Equal Opportunities and Diversity Council.

Switch and Data - Investor Relations - Overview

Customers, log in here for our online interconnect portal, Web MarketPlace and other useful utilities. These demanding businesses rely on our expertise to provide safe and secure network exchange points to connect with each other, their customers and the global Internet. Switch and Data To Withhold First Quarter 2010 Financial Results.

Synageva Investor Relations

Effective June 23, 2015 Synageva BioPharma Corp. is now part of Alexion Pharmaceuticals, Inc. You will be redirected in 10 seconds. Synageva is a biopharmaceutical company dedicated to discovering, developing and delivering medicines for patients with rare diseases and high unmet medical needs. We are passionate about our commitment to improving the lives of patients for generations .